ferrous lactate profile

Ferrous lactate is an iron(II) salt of lactic acid, with the chemical formula Fe(C3H5O3)2. It is a pale green, crystalline compound that is highly soluble in water. It is commonly used as an iron supplement, particularly in the treatment of iron deficiency anemia. Ferrous lactate is produced by reacting lactic acid with iron oxide. It is well-absorbed by the body and has a low incidence of gastrointestinal side effects. Studies have shown that ferrous lactate is effective in increasing iron levels in individuals with iron deficiency. Its importance lies in its ability to address iron deficiency, a prevalent nutritional problem globally. Research continues to investigate its potential applications in various areas, including its role in enhancing athletic performance and promoting cognitive function. '

ID Source	ID
PubMed CID	22197
SCHEMBL ID	191421
MeSH ID	M0264942

Synonym
ferrous lactate
iron dilactate
iron(2+) lactate, (2:1)
hsdb 462
iron(2+) lactate
einecs 227-608-0
lactic acid, iron(2+) salt (2:1)
iron(ii) lactate
iron(2+) 2-hydroxypropanoate, (2:1)
5905-52-2
85993-25-5
iron, bis((2s)-2-(hydroxy-kappao)propanoato-kappao)-, (t-4)-
einecs 289-080-8
ferro drops
ferrous lactate [nf]
5ju4c2l5a0 ,
unii-5ju4c2l5a0
iron(ii) lactate hydrate
AKOS015901562
SCHEMBL191421
ferrous lactate [mi]
ins-585
iron(ii) 2-hydroxypropanoate
e 585
ferrous lactate [fcc]
lactic acid, iron(ii) salt (2:1)
e-585
iron, bis(2-(hydroxy-.kappa.o)propanoato-.kappa.o)-, (t-4)-
ferrous lactate [hsdb]
ferrous lactate [inci]
ferrous lactate [who-dd]
ins no.585
2-hydroxypropanoate;iron(2+)
Q836793
92542-68-2
DTXSID501018671

Excerpt	Reference	Relevance
"Ferrous lactate treatments corresponding to 0, 2, 5, and 12.5mg/kg drinking water concentrations were delivered through the abomasum at 10 L/d to 4 lactating dairy cows over 4 periods (1 wk infusion/period) in a Latin square design."	( Effects of mineral content of bovine drinking water: does iron content affect milk quality? Dietrich, AD; Duncan, SE; Knowlton, KF; Mann, GR; O'Keefe, SF, 2013)	1.11

Occurs in Manufacturing (47 Items)

Item	Process	Frequency
Plant-based foods	core-ingredient	212
Plant-based foods and beverages	core-ingredient	212
Pastas	core-ingredient	210
Cereals and potatoes	core-ingredient	206
Cereals and their products	core-ingredient	206
Spaghetti	core-ingredient	11
Penne Rigate	core-ingredient	10
Penne	core-ingredient	10
it:Acini di pepe	core-ingredient	4
Meals	core-ingredient	3
Orecchiette	core-ingredient	3
it:Ditalini	core-ingredient	3
Pasta dishes	core-ingredient	2
Dry pastas	core-ingredient	2
Durum wheat pasta	core-ingredient	2
Cereal pastas	core-ingredient	2
en:Cereals and their products	core-ingredient	1
en:Cereals and potatoes	core-ingredient	1
en:Plant-based foods	core-ingredient	1
en:Plant-based foods and beverages	core-ingredient	1
Whole-wheat-spaghetti	core-ingredient	1
Durum wheat semolinas	core-ingredient	1
Wheat semolinas	core-ingredient	1
Cereal semolinas	core-ingredient	1
Frozen foods	core-ingredient	1
Salted snacks	core-ingredient	1
Black pitted olives	core-ingredient	1
Pitted olives	core-ingredient	1
Black olives	core-ingredient	1
Olives	core-ingredient	1
Plant-based pickles	core-ingredient	1
Olive tree products	core-ingredient	1
Pickles	core-ingredient	1
Fusilli	core-ingredient	1
Linguine	core-ingredient	1
Ziti	core-ingredient	1
Durum-wheat-farfal	core-ingredient	1
es:Pastas de trigo duro integrales o semi-integrales	core-ingredient	1
Whole or semi-whole durum wheat pasta	core-ingredient	1
Rigatoni	core-ingredient	1
Pasta	core-ingredient	1
Salads	core-ingredient	1
Prepared salads	core-ingredient	1
Beverages	core-ingredient	1
Seeds	core-ingredient	1
Dry durum wheat pasta	core-ingredient	1
Cooked unsalted dried pasta	core-ingredient	1

Class	Description
lactate salt	Any organic salt that has lactate as the cation.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Timeframe	Studies, This Drug (%)	All Drugs %
pre-1990	2 (13.33)	18.7374
1990's	2 (13.33)	18.2507
2000's	6 (40.00)	29.6817
2010's	5 (33.33)	24.3611
2020's	0 (0.00)	2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Publication Type	This drug (%)	All Drugs (%)
Trials	3 (15.79%)	5.53%
Reviews	0 (0.00%)	6.00%
Case Studies	1 (5.26%)	4.05%
Observational	0 (0.00%)	0.25%
Other	15 (78.95%)	84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Substance	Relationship Strength	Studies	Trials	Classes	Roles
citric acid, anhydrous Citric Acid: A key intermediate in metabolism. It is an acid compound found in citrus fruits. The salts of citric acid (citrates) can be used as anticoagulants due to their calcium chelating ability.. citric acid : A tricarboxylic acid that is propane-1,2,3-tricarboxylic acid bearing a hydroxy substituent at position 2. It is an important metabolite in the pathway of all aerobic organisms.	3.41	1	1	tricarboxylic acid	antimicrobial agent; chelator; food acidity regulator; fundamental metabolite
nitrates Nitrates: Inorganic or organic salts and esters of nitric acid. These compounds contain the NO3- radical.	2.04	1	0	monovalent inorganic anion; nitrogen oxoanion; reactive nitrogen species
chlorpheniramine Chlorpheniramine: A histamine H1 antagonist used in allergic reactions, hay fever, rhinitis, urticaria, and asthma. It has also been used in veterinary applications. One of the most widely used of the classical antihistaminics, it generally causes less drowsiness and sedation than PROMETHAZINE.. chlorphenamine : A tertiary amino compound that is propylamine which is substituted at position 3 by a pyridin-2-yl group and a p-chlorophenyl group and in which the hydrogens attached to the nitrogen are replaced by methyl groups. A histamine H1 antagonist, it is used to relieve the symptoms of hay fever, rhinitis, urticaria, and asthma.	2.04	1	0	monochlorobenzenes; pyridines; tertiary amino compound	anti-allergic agent; antidepressant; antipruritic drug; H1-receptor antagonist; histamine antagonist; serotonin uptake inhibitor
ebastine [no description available]	2.04	1	0	organic molecular entity
malondialdehyde Malondialdehyde: The dialdehyde of malonic acid.. malonaldehyde : A dialdehyde that is propane substituted by two oxo groups at the terminal carbon atoms respectively. A biomarker of oxidative damage to lipids caused by smoking, it exists in vivo mainly in the enol form.	2.08	1	0	dialdehyde	biomarker
zinc oxide Zinc Oxide: A mild astringent and topical protectant with some antiseptic action. It is also used in bandages, pastes, ointments, dental cements, and as a sunblock.	2.04	1	0	zinc molecular entity
ammonium nitrate ammonium nitrate: structure. ammonium nitrate : The ammonium salt of nitric acid.	2.04	1	0	ammonium salt; inorganic molecular entity; inorganic nitrate salt	explosive; fertilizer; oxidising agent
phosphoric acid, trisodium salt [no description available]	2.04	1	0	sodium phosphate
ferrous sulfate ferrous sulfate: Ferro-Gradumet is ferrous sulfate in controlled release form; RN given refers to Fe(+2)[1:1] salt. iron(2+) sulfate (anhydrous) : A compound of iron and sulfate in which the ratio of iron(2+) to sulfate ions is 1:1. Various hydrates occur naturally - most commonly the heptahydrate, which loses water to form the tetrahydrate at 57degreeC and the monohydrate at 65degreeC.	4.69	6	1	iron molecular entity; metal sulfate	reducing agent
ferrous chloride ferrous chloride: induces convulsions; RN given refers to parent cpd	2.08	1	0	iron coordination entity
ferric sulfate ferric sulfate: RN given refers to Fe(+3)[3:2] salt). iron(3+) sulfate : A compound of iron and sulfate in which the ratio of iron(3+) to sulfate ions is 3:2.	2.08	1	0	iron molecular entity; metal sulfate	astringent; catalyst; mordant
dexchlorpheniramine dexchlorpheniramine: RN given refers to parent cpd(S)-isomer	2.04	1	0	chlorphenamine
glucaric acid Glucaric Acid: A sugar acid derived from D-glucose in which both the aldehydic carbon atom and the carbon atom bearing the primary hydroxyl group are oxidized to carboxylic acid groups.. D-glucaric acid : The D-enantiomer of glucaric acid.. glucaric acid : A hexaric acid derived by oxidation of sugar such as glucose with nitric acid.	3.37	1	1	glucaric acid	antineoplastic agent
magnesium peroxide [no description available]	2.13	1	0	organic molecular entity
hydroxyl radical Hydroxyl Radical: The univalent radical OH. Hydroxyl radical is a potent oxidizing agent.	2.13	1	0	oxygen hydride; oxygen radical; reactive oxygen species
deoxyribose [no description available]	2.13	1	0	deoxypentose	human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
phosphorus Phosphorus: A non-metal element that has the atomic symbol P, atomic number 15, and atomic weight 31. It is an essential element that takes part in a broad variety of biochemical reactions.	2.08	1	0	monoatomic phosphorus; nonmetal atom; pnictogen	macronutrient
losartan potassium Erythropoietin: Glycoprotein hormone, secreted chiefly by the KIDNEY in the adult and the LIVER in the FETUS, that acts on erythroid stem cells of the BONE MARROW to stimulate proliferation and differentiation.	3.37	1	1
ferrous gluconate ferrous gluconate: iron important in this cpd; RN given refers to ferrous cpd	7.37	2	0
piperidines Piperidines: A family of hexahydropyridines.	2.04	1	0
ferric oxide, saccharated Ferric Oxide, Saccharated: A glucaric acid-iron conjugate that is used in the treatment of IRON-DEFICIENCY ANEMIA, including in patients with chronic kidney disease, when oral iron therapy is ineffective or impractical.	3.37	1	1
ferric ammonium citrate ferric ammonium citrate: RN given refers to unspecified NH4-Fe(+3) salt. ferric ammonium citrate : A mixture of indefinite composition that contains ferric and ammonium cations and citrate(3-) anions, ferric ammonium citrate may be obtained as red crystals or a brownish yellow powder or as green crystals or powder. It is added to foods as an acidity regulator and anticaking agent. It is also used as a positive oral contrast agent in magnetic resonance imaging, and was formerly administered orally as a source of iron for the treatment of iron-deficiency anaemia.	3.41	1	1

Condition	Relationship Strength	Studies	Trials
Anaphylactic Reaction [description not available]	2.04	1	0
Allergy, Drug [description not available]	2.04	1	0
Anaphylaxis An acute hypersensitivity reaction due to exposure to a previously encountered ANTIGEN. The reaction may include rapidly progressing URTICARIA, respiratory distress, vascular collapse, systemic SHOCK, and death.	2.04	1	0
Drug Hypersensitivity Immunologically mediated adverse reactions to medicinal substances used legally or illegally.	2.04	1	0
Anemia, Hypochromic Anemia characterized by a decrease in the ratio of the weight of hemoglobin to the volume of the erythrocyte, i.e., the mean corpuscular hemoglobin concentration is less than normal. The individual cells contain less hemoglobin than they could have under optimal conditions. Hypochromic anemia may be caused by iron deficiency from a low iron intake, diminished iron absorption, or excessive iron loss. It can also be caused by infections or other diseases, therapeutic drugs, lead poisoning, and other conditions. (Stedman, 25th ed; from Miale, Laboratory Medicine: Hematology, 6th ed, p393)	1.93	1	0
Anemia A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN.	3.74	2	1
Iron Overload An excessive accumulation of iron in the body due to a greater than normal absorption of iron from the gastrointestinal tract or from parenteral injection. This may arise from idiopathic hemochromatosis, excessive iron intake, chronic alcoholism, certain types of refractory anemia, or transfusional hemosiderosis. (From Churchill's Illustrated Medical Dictionary, 1989)	2.02	1	0
Infant, Premature, Diseases Diseases that occur in PREMATURE INFANTS.	3.37	1	1
Anemia Neonatorum [description not available]	3.37	1	1
Anemia, Neonatal The mildest form of erythroblastosis fetalis in which anemia is the chief manifestation.	3.37	1	1
Anemias, Iron-Deficiency [description not available]	3.39	1	1
Innate Inflammatory Response [description not available]	3.39	1	1
Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.	3.39	1	1
Anemia, Iron-Deficiency Anemia characterized by decreased or absent iron stores, low serum iron concentration, low transferrin saturation, and low hemoglobin concentration or hematocrit value. The erythrocytes are hypochromic and microcytic and the iron binding capacity is increased.	3.39	1	1

ferrous lactate

Cross-References

Synonyms (36)

Research Excerpts

Treatment

Occurs in Manufacturing (47 Items)

Drug Classes (1)

Research

Studies (15)

Market Indicators

Research Demand Index: 40.10

Study Types

ferrous lactate

Cross-References

Synonyms (36)

Research Excerpts

Treatment

Occurs in Manufacturing (47 Items)

Drug Classes (1)

Research

Studies (15)

Market Indicators

Research Demand Index: 40.10

Study Types

Related Drugs (22)

Related Conditions (14)